Business
First order as Injectaclad supplier
Light Science Technologies Holdings plc has secured its first order for the Injectaclad fire-resistant graphite barrier system, valued at approximately £0.41 million, following the recent acquisition of RLUK Injection Ltd. This material order is expected to be recognized in the current financial year and will be called off over a 19-week project for a residential building in East Yorkshire, commencing in early May 2026. Commitments for Injectaclad product have already been obtained from five of the eleven accredited installation contractors, indicating the successful integration of this new, higher-margin revenue stream and positioning the company to benefit from the ongoing focus on cladding remediation programs. Disclaimer*
About this update from Light Science Technologies Holdings Plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596 / 2014 WHICH FORMS PART OF UNITED KINGDOM LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Light Science Technologies Holdings plc ("LSTH", "Light Science", the "Company" or the "Group") First Injectaclad Order Secured Following Acquisition Successful Completion of the Initial Integration Phase Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business, announces that its Passive Fire Protection ("PFP") division has secured its first order as a supplier of the fire-resistant graphite barrier system, Injectaclad. This milestone follows completion of the acquisition of RLUK Injection Ltd ("RLUK") on 14 April 2026 (the "Acquisition"). The Company has received a contract confirmation from one of its approved Injectaclad installers requiring c.£0.41m of Injectaclad material to be called off over the 19-week project completion window. Work is scheduled to commence in early May 2026 on a five-storey residential building in East Yorkshire. Group revenue delivery of c.£0.41m relating to this project is expected to be fully recognised in the current financial year, subject to the project progressing as anticipated. In just over two weeks since the Acquisition, commitments for Injectaclad product have now been secured from 5 of the 11 quality-accredited installation contractors, highlighting the growing impact of this new revenue stream for the Company. Strong progress in enhancing systems and stakeholder relationships Prior to completing the Acquisition, LSTH operated solely as an Injectaclad quality-accredited installation contractor. A central strategic rationale for acquiring RLUK was to establish a higher-margin revenue stream through supplying Injectaclad materials to its approved installation contractors. There are currently 11 qualified installers, each with a substantial project pipeline. This positions the Group to capture a greater share of the value chain and accelerate growth within the PFP division, particularly as the Building Safety Regulator ("BSR") continues to focus on reducing delays and expedit...
View stock analysis, news, and events for Light Science Technologies Holdings Plc